Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuhei Nishiguchi

Showing results (31-40 of 303) with videos related to

Pageof 31
Sort By:
In Vivo (Athens, Greece)|June 28, 2021
Factors Associated With Longitudinal QOL Change in Patients With Chronic Liver DiseasesHiroki Nishikawa, Kazunori Yoh, Hirayuki Enomoto, et al.
Drug Metabolism and Pharmacokinetics|March 9, 2010
LKM-1 sera from autoimmune hepatitis patients that recognize ERp57, carboxylesterase 1 and CYP2D6Ryo Komurasaki, Susumu Imaoka, Naomichi Tada, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 3, 2016
Japan Society of Hepatology guidelines for sarcopenia in liver disease (1st edition): Recommendation from the working group for creation of sarcopenia assessment criteriaHiroki Nishikawa, Makoto Shiraki, Akira Hiramatsu, et al.
International Journal of Molecular Medicine|June 29, 2021
Pathophysiology and mechanisms of primary sarcopenia (Review)Hiroki Nishikawa, Shinya Fukunishi, Akira Asai, et al.
Heart and Vessels|October 2, 2003
Prevalence of hepatitis C virus infection among patients with hypertrophic cardiomyopathyMasakazu Teragaki, Shuhei Nishiguchi, Kazuhide Takeuchi, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|April 4, 2017
Clinical utility of bioimpedance analysis in liver cirrhosisHiroki Nishikawa, Hirayuki Enomoto, Yoshinori Iwata, et al.
Journal of Surgical Oncology|July 23, 2008
Response to interferon therapy affects risk factors for postoperative recurrence of hepatitis C virus-related hepatocellular carcinomaTakahiro Uenishi, Shuhei Nishiguchi, Shogo Tanaka, et al.
Journal of Gastroenterology|October 1, 2009
Etiology of liver cirrhosis in Japan: a nationwide surveyKojiro Michitaka, Shuhei Nishiguchi, Yutaka Aoyagi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 27, 2021
Clinical impact of the finger-circle test in patients with liver diseasesHiroki Nishikawa, Kazunori Yoh, Hirayuki Enomoto, et al.
Annals of Translational Medicine|May 14, 2021
Combined grip strength and calf circumference as a useful prognostic system in patients with liver diseases: a large cohort studyHiroki Nishikawa, Kazunori Yoh, Hirayuki Enomoto, et al.
Pageof 31

Showing results (31-40 of 303) with videos related to

Sort By:
Pageof 31
In Vivo (Athens, Greece)|June 28, 2021
Factors Associated With Longitudinal QOL Change in Patients With Chronic Liver DiseasesHiroki Nishikawa, Kazunori Yoh, Hirayuki Enomoto, et al.
Drug Metabolism and Pharmacokinetics|March 9, 2010
LKM-1 sera from autoimmune hepatitis patients that recognize ERp57, carboxylesterase 1 and CYP2D6Ryo Komurasaki, Susumu Imaoka, Naomichi Tada, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 3, 2016
Japan Society of Hepatology guidelines for sarcopenia in liver disease (1st edition): Recommendation from the working group for creation of sarcopenia assessment criteriaHiroki Nishikawa, Makoto Shiraki, Akira Hiramatsu, et al.
International Journal of Molecular Medicine|June 29, 2021
Pathophysiology and mechanisms of primary sarcopenia (Review)Hiroki Nishikawa, Shinya Fukunishi, Akira Asai, et al.
Heart and Vessels|October 2, 2003
Prevalence of hepatitis C virus infection among patients with hypertrophic cardiomyopathyMasakazu Teragaki, Shuhei Nishiguchi, Kazuhide Takeuchi, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|April 4, 2017
Clinical utility of bioimpedance analysis in liver cirrhosisHiroki Nishikawa, Hirayuki Enomoto, Yoshinori Iwata, et al.
Journal of Surgical Oncology|July 23, 2008
Response to interferon therapy affects risk factors for postoperative recurrence of hepatitis C virus-related hepatocellular carcinomaTakahiro Uenishi, Shuhei Nishiguchi, Shogo Tanaka, et al.
Journal of Gastroenterology|October 1, 2009
Etiology of liver cirrhosis in Japan: a nationwide surveyKojiro Michitaka, Shuhei Nishiguchi, Yutaka Aoyagi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 27, 2021
Clinical impact of the finger-circle test in patients with liver diseasesHiroki Nishikawa, Kazunori Yoh, Hirayuki Enomoto, et al.
Annals of Translational Medicine|May 14, 2021
Combined grip strength and calf circumference as a useful prognostic system in patients with liver diseases: a large cohort studyHiroki Nishikawa, Kazunori Yoh, Hirayuki Enomoto, et al.
Pageof 31